Overview

iproniazid


Show Summary Details

Quick Reference

An antidepressant drug, the first of the monoamine oxidase inhibitors (MAOIs), originally developed in 1951 for the treatment of tuberculosis. Also called Marsilid (trademark). [From i(so)niazid an earlier compound used for treating tuberculosis+pro(pyl) indicating a compound containing the monovalent group C3H7]

Subjects: Psychology.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.